Overview


An ovarian endometrioma, or cyst, is a cystic mass caused by ectopic endometrial tissues within the ovary. It may contain thick, brown, tarlike fluid, sometimes referred to as a "chocolate cyst". Endometriomas refer to cystic lesions that result from endometriosis. Endometriomas often adhere densely to the surrounding structures like the peritoneum or fallopian tubes. Endometriosis can occur as classic implants on either one or both ovaries, but can also be found deep inside them. Endometriosis of the deep ovarian can form dark-colored, fluid-filled cysts that can vary in size and are called "chocolate or endometriomas". An ultrasound image of the pelvis can be used to diagnose an endometrioma. However, a microscopic examination must be done to determine the exact cause. Endometriomas can pose a serious threat to a woman’s reproductive health, except for cancerous tumors. These lesions can be very difficult to treat and may cause damage to healthy ovarian tissue. This could lead to premature or even early ovarian failure, decreased ovarian function, and problems with ovulation. Endometriomas can also result in invasive and harmful pelvic surgeries that can cause a premature or partial loss of ovarian functions. These cysts can present a medical problem even for women who are receiving fertility treatments, such as assisted reproduction technologies (ART).
Endometriosis refers to a common and estrogen-dependent, inflammatory gynecologic condition in which normal endometrial tissue exists outside of the uterine cavities. Endometriomas can be cystic lesions caused by endometriosis. Endometriomas most often occur in the ovaries. Endometriosis can affect reproductive-aged women. It is a common cause of chronic pain, dyspareunia or dysmenorrhea, and infertility. Globally, women's illnesses are receiving more attention. More innovative drugs and treatments for their pain are being developed. Endometriosis ranks among the most common conditions. Women suffering from endometriosis are seeing significant improvements in their treatment. This is due to the incorporation of cutting-edge technologies. Endometriosis treatment is in high demand. This has led to significant efforts to improve diagnostic methods. Also, the market for endometriosis treatment is growing rapidly because women from all walks of life are becoming more aware of their issues and speaking out. Endometriosis refers to a painful gynecological disorder in which endometriosis tissue, which usually lines the uterus and covers the fallopian tubes, is spread outside or beyond the uterus. Endometriosis manifests as painful intercourse, menstrual pain, or irregular periods. Endometriosis sufferers are becoming more aware of possible treatment options. There is a shift in focus in research and development as a result of the growing incidence of the condition. In order to offer better treatment options, the government is investing in infrastructure for healthcare. The market is booming as more drugs and equipment are needed to treat endometriosis.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Endometrioma Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Endometrioma Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Pfizer Inc
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd
• Sanofi
• Boehringer Ingelheim International GmbH
• AstraZeneca
• Johnson
Johnson Private Limited
• Bayer AG
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type
• Superficial Peritoneal Lesion
• Endometrioma Ovarian Lesion
• Deeply Infiltrating Endometriosis
By Treatment
• Pain Medication
• Hormone Therapy
• Others
By End User
• Hospital
• Homecare
• Specialty Clinics
• Others
By Region
• North America
Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Endometrioma Market By Type, By Treatment, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Endometrioma Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Endometrioma Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Endometrioma Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Endometrioma Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Superficial Peritoneal Lesion
        2. Endometrioma Ovarian Lesion
        3. Deeply Infiltrating Endometriosis
  • 8.   Endometrioma Market, By Treatment Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Pain Medication
        2. Hormone Therapy
        3. Others
  • 9.   Endometrioma Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospital
        2. Homecare
        3. Specialty Clinics
        4. Others
  • 10.   North America Endometrioma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Endometrioma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Endometrioma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Endometrioma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
          2. Mylan N.V.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Teva Pharmaceutical Industries Ltd
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sanofi
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Boehringer Ingelheim International GmbH
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. AstraZeneca
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Johnson
      Johnson Private Limited
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bayer AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients